Provided by Tiger Fintech (Singapore) Pte. Ltd.

Chinook Therapeutics, Inc.

40.39
0.0000
Volume:- -
Turnover:- -
Market Cap:2.90B
PE:-11.49
High:40.39
Open:40.39
Low:40.39
Close:40.39
Loading ...
Jun 13, 2023

Major Issues Report

Form 8-K - Current report
Jun 12, 2023

Major Issues Report

Form 8-K - Current report
May 09, 2023

Major Issues Report

8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 24, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 13, 2023

Major Issues Report

8-K - Current report
Mar 13, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 27, 2023

Major Issues Report

8-K - Current report
Feb 27, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 24, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 28, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 10, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 10, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 22, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership